Shanghai New High Technology Service Centre

Shanghai New High Technology Service Centre is a pharmaceutical development and technology transfer organization primarily affiliated with the Shanghai Institute of Materia Medica (SIMM) of the Chinese Academy of Sciences. The center serves as a commercialization vehicle for innovative drug candidates discovered through academic research, managing intellectual property, clinical trial applications, and industrial partnerships. It is best known for its role in the development of Antofloxacin, the first fluoroquinolone antibiotic developed entirely within China. The center's portfolio spans a wide range of therapeutic areas, including oncology, cardiovascular diseases, and infectious diseases. By bridging the gap between laboratory discovery and market entry, the center facilitates the translation of high-level scientific research into clinical therapies.